Healthcare: We See Value in the Drug and Biotech Industries
October 05, 2016 at 08:00 AM EDT
Overblown concerns over drug pricing in the U.S. are creating attractive valuations for the more innovative drug companies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.